Saba Capital Management, L.P. has made a notable move by acquiring an additional 100 shares of Gabelli Healthcare & WellnessRx Trust, as reported in their recent SEC filing. This acquisition, priced at $10.18 per share, brings Saba's total holdings in Gabelli to approximately 2.18 million shares. The transaction underscores Saba's strategic focus on the healthcare sector, which remains a competitive landscape.

Saba Capital Management, L.P., based in New York, is an investment management firm known for its active investment strategies. The firm operates under the Central Index Key (CIK) number 0001510281. The recent filing, dated November 4, 2026, is a Form 4, indicating changes in the ownership of securities by an insider.

According to the filing, the acquisition took place on November 3, 2026. The filing states, "The securities reported herein are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." This highlights Saba's role as a significant investor in Gabelli Healthcare & WellnessRx Trust, which is listed under the trading symbol GRX.

This transaction may impact various stakeholders, including Gabelli Healthcare & WellnessRx Trust and its investors. With Saba Capital Management holding a substantial portion of Gabelli's shares, the firm’s investment decisions could influence the company's strategic direction and market perception.

The filing does not say what happens next regarding this acquisition or any further actions by Saba Capital Management.